Cavan M. Redmond - Jun 24, 2021 Form 4 Insider Report for OncoCyte Corp (OCX)

Role
Director
Signature
/s/ Cavan Redmond
Stock symbol
OCX
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
6/28/2021, 08:36 PM
Next filing
Mar 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Option to Purchase Common Stock Award $0 +45K $0.00 45K Jun 24, 2021 Common Stock 45K $5.46 Direct F1
transaction OCX Restricted Stock Units Award $0 +10K $0.00 10K Jun 24, 2021 Common Stock 10K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
F2 The Restricted Stock Units shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.